Imperial College London Featured PhD Programmes
Gdansk University of Technology Featured PhD Programmes
Solent University Featured PhD Programmes

alzheimer PhD Projects, Programmes & Scholarships

We have 64 alzheimer PhD Projects, Programmes & Scholarships

Discipline

Discipline

All disciplines

Location

Location

All locations

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

All Funding


We have 64 alzheimer PhD Projects, Programmes & Scholarships

PhD saved successfully

AI and Machine Learning for the diagnosis and monitoring of Parkinson’s and Alzheimer’s disease

  Research Group: Intelligent Systems and Nanoscience
The Department has long-standing research collaborations with hospitals and medical centres worldwide developing new approaches to the diagnosis and monitoring of neurological conditions, including Parkinson’s and Alzheimer’s. Read more

4-year PhD Studentship: The relationship of psychological symptoms in dementias to genetic risk

Behavioural and neuropsychological symptoms are very common in dementias such as Alzheimer's Disease. These behavioural and neuropsychological symptoms cause considerable distress, are difficult to treat and the underlying biology remains unclear. Read more

Neuroinflammation, glial cell dysfunction & neurodegenerative diseases

Neurodegenerative disorders, such as Alzheimer’s disease, are often associated with chronic neuroinflammation and glial cell dysfunction that acts to exacerbate neuronal damage and loss of synapses. Read more

The breakdown of neurovascular coupling in the diseased state specifically Epilepsy and Alzheimer’s disease

Epilepsy is the most common neurological condition in the UK, affecting 1 – 2 % of the population. Epilepsies often involve only a small area of the brain - the epileptic focus – and the abnormal activity can propagate out from there. Read more

Developing biodegradable long acting drug delivery systems for the treatment of chronic conditions

Non-adherence to treatment costs the NHS more than £500M each year. Adherence is especially important when treating patients with chronic conditions that require lifetime pharmacological treatment, such as schizophrenia, Parkinson’s disease, HIV and Alzheimer’s disease. Read more

Exploring how Natural Language Processing (NLP) can help with the diagnosis of dementia

  Research Group: Visual Computing
The Alzheimer’s Society acknowledges the COVID-19 pandemic led to a significant decrease in dementia diagnosis rates from 67.6% in February 2020 to 63.5% in June 2020. Read more

Identifying cognitive and biochemical changes underlying lifestyle risk factors for dementia

  Research Group: Pharmacology and Experimental Therapeutics
Dementia describes a group of age-associated conditions of which cognitive decline is a major feature. Alzheimer’s disease (AD) is the most common cause of dementia and is characterised by the onset of a gradual cognitive decline. Read more

Computational Modelling of Ageing Brains: Virtual Populations for In Silico Clinical Trials

Training. The University of Liverpool has set up a Doctoral Training Network in Technologies for Healthy Ageing to train the next generation of physical scientists and engineers to develop novel technologies and devices to address the challenges faced by older people and our clinical colleagues who work with them. Read more

Synaptic dysfunction in Drosophila models of neurodegenerative diseases

Almost a million of people in the UK suffer from neurodegenerative disorders. Alzheimer’s disease (AD), dementia with Lewy bodies (DLB), and frontotemporal dementia (FTD) are the most common causes of neurodegenerative dementias. Read more

Filtering Results